Build world-changing business opportunities with our technology.
Build world-changing business opportunities with our technology.
Our treatment is based on in-cell technology that rapidly expresses proteins or inhibits genes when a DNA sequence is detected. The core technology is the subject of international patent applications filed under the PCT through WIPO.
This technology can support several business applications, including:
Treatment of diseases caused by gene mutations in stem cells
Not all gene mutations lead to cancer. Gene mutations in stem cells are associated with many diseases. With our technology, the cells with the gene mutation can be targeted, which does not always mean that these cells have to be destroyed.
Ultra-targeted biopesticides
Locust outbreaks occur regularly around the world. The 2019–2021 outbreak in Africa was Kenya's worst in 70 years and the worst in 25 years in Ethiopia, Somalia, and India. In 2022, locust swarms destroyed crops in Sardinia, Europe. According to the World Food Programme (WFP), such outbreaks cause billions in losses.
These outbreaks are currently controlled with conventional chemical pesticides because biological pesticides act too slowly. Chemical pesticides, however, are harmful to the environment.
Biopesticides based on our technology act faster than other biopesticides. By targeting locust-specific DNA sequences, they can be designed to be harmless to the environment.
Contact us if you are interested in licensing our technology.
